Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications
- PMID: 39542988
- DOI: 10.1007/s11684-024-1094-2
Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications
Abstract
Existing epidemiologic and clinical studies have demonstrated that obesity is associated with the risk of a variety of cancers. In recent years, an increasing number of experimental and clinical studies have unraveled the complex relationship between obesity and cancer risk and the underlying mechanisms. Obesity-induced abnormalities in immunity and biochemical metabolism, including chronic inflammation, hormonal disorders, dysregulation of adipokines, and microbial dysbiosis, may be important contributors to cancer development and progression. These contributors play different roles in cancer development and progression at different sites. Lifestyle changes, weight loss medications, and bariatric surgery are key approaches for weight-centered, obesity-related cancer prevention. Treatment of obesity-related inflammation and hormonal or metabolic dysregulation with medications has also shown promise in preventing obesity-related cancers. In this review, we summarize the mechanisms through which obesity affects the risk of cancer at different sites and explore intervention strategies for the prevention of obesity-associated cancers, concluding with unresolved questions and future directions regarding the link between obesity and cancer. The aim is to provide valuable theoretical foundations and insights for the in-depth exploration of the complex relationship between obesity and cancer risk and its clinical applications.
Keywords: cancer prevention; cancer risk; carcinogenesis; obesity; obesity-associated cancers.
© 2024. Higher Education Press.
Conflict of interest statement
Compliance with ethics guidelines. Xiaoye Shi, Aimin Jiang, Zhengang Qiu, Anqi Lin, Zaoqu Liu, Lingxuan Zhu, Weiming Mou, Quan Cheng, Jian Zhang, Kai Miao, and Peng Luo declare that they have no conflict of interest. This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.
Similar articles
-
Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.Recent Results Cancer Res. 2016;208:199-217. doi: 10.1007/978-3-319-42542-9_11. Recent Results Cancer Res. 2016. PMID: 27909909 Review.
-
The Impact of Obesity on Breast Cancer.Curr Oncol Rep. 2018 Apr 11;20(6):47. doi: 10.1007/s11912-018-0688-8. Curr Oncol Rep. 2018. PMID: 29644507 Review.
-
Gender Differences in Obesity-Related Cancers.Curr Obes Rep. 2021 Jun;10(2):100-115. doi: 10.1007/s13679-021-00426-0. Epub 2021 Feb 1. Curr Obes Rep. 2021. PMID: 33523397 Review.
-
Obesity, adipokines and cancer: an update.Clin Endocrinol (Oxf). 2015 Aug;83(2):147-56. doi: 10.1111/cen.12667. Epub 2014 Dec 29. Clin Endocrinol (Oxf). 2015. PMID: 25393563 Review.
-
Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression.Int J Mol Sci. 2021 Feb 1;22(3):1444. doi: 10.3390/ijms22031444. Int J Mol Sci. 2021. PMID: 33535537 Free PMC article. Review.
Cited by
-
From Liking to Following: The Role of Food Preferences, Taste Perception, and Lifestyle Factors in Adherence to the Mediterranean Diet Among Young Individuals.Nutrients. 2025 Feb 6;17(3):600. doi: 10.3390/nu17030600. Nutrients. 2025. PMID: 39940456 Free PMC article.
-
Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study.EClinicalMedicine. 2025 May 11;83:103213. doi: 10.1016/j.eclinm.2025.103213. eCollection 2025 May. EClinicalMedicine. 2025. PMID: 40599584 Free PMC article.
-
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence.Biomark Res. 2025 Mar 27;13(1):50. doi: 10.1186/s40364-025-00765-3. Biomark Res. 2025. PMID: 40140925 Free PMC article. Review.
-
[Diagnostics and treatment of gout : S3 guideline of the German Society for Rheumatology and Clinical Immunology (DGRh, lead management) and participating professional societies: German Society for Internal Medicine (DGIM), German Society for General Medicine and Family Medicine (DEGAM), German Society for Nephrology (DGfN), German Society for Orthopaedic and Trauma Surgery (DGOU), German Society for Nutritional Medicine (DGEM), German Roentgen Society-Society for Medical Radiology (DRG), German Rheumatism League].Z Rheumatol. 2025 Aug;84(Suppl 2):51-81. doi: 10.1007/s00393-025-01634-y. Epub 2025 Jul 21. Z Rheumatol. 2025. PMID: 40689975 Review. German. No abstract available.
-
Preoperative kidney tumor risk estimation with AI: From logistic regression to transformer.PLoS One. 2025 May 30;20(5):e0323240. doi: 10.1371/journal.pone.0323240. eCollection 2025. PLoS One. 2025. PMID: 40446057 Free PMC article.
References
-
- Conway B, Rene A. Obesity as a disease: no lightweight matter. Obes Rev 2004; 5(3): 145–151 - DOI
-
- Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Curr Obes Rep 2015; 4(3): 363–370 - DOI
-
- World Health Organization. Obesity and overweight. 2024. Available at the website of World Health Organization
-
- GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, Salama JS, Vos T, Abate KH, Abbafati C, Ahmed MB, Al-Aly Z, Alkerwi A, Al-Raddadi R, Amare AT, Amberbir A, Amegah AK, Amini E, Amrock SM, Anjana RM, Ärnlöv J, Asayesh H, Banerjee A, Barac A, Baye E, Bennett DA, Beyene AS, Biadgilign S, Biryukov S, Bjertness E, Boneya DJ, Campos-Nonato I, Carrero JJ, Cecilio P, Cercy K, Ciobanu LG, Cornaby L, Damtew SA, Dandona L, Dandona R, Dharmaratne SD, Duncan BB, Eshrati B, Esteghamati A, Feigin VL, Fernandes JC, Fürst T, Gebrehiwot TT, Gold A, Gona PN, Goto A, Habtewold TD, Hadush KT, Hafezi-Nejad N, Hay SI, Horino M, Islami F, Kamal R, Kasaeian A, Katikireddi SV, Kengne AP, Kesavachandran CN, Khader YS, Khang YH, Khubchandani J, Kim D, Kim YJ, Kinfu Y, Kosen S, Ku T, Defo BK, Kumar GA, Larson HJ, Leinsalu M, Liang X, Lim SS, Liu P, Lopez AD, Lozano R, Majeed A, Malekzadeh R, Malta DC, Mazidi M, McAlinden C, McGarvey ST, Mengistu DT, Mensah GA, Mensink GBM, Mezgebe HB, Mirrakhimov EM, Mueller UO, Noubiap JJ, Obermeyer CM, Ogbo FA, Owolabi MO, Patton GC, Pourmalek F, Qorbani M, Rafay A, Rai RK, Ranabhat CL, Reinig N, Safiri S, Salomon JA, Sanabria JR, Santos IS, Sartorius B, Sawhney M, Schmidhuber J, Schutte AE, Schmidt MI, Sepanlou SG, Shamsizadeh M, Sheikhbahaei S, Shin MJ, Shiri R, Shiue I, Roba HS, Silva DAS, Silverberg JI, Singh JA, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadese F, Tedla BA, Tegegne BS, Terkawi AS, Thakur JS, Tonelli M, Topor-Madry R, Tyrovolas S, Ukwaja KN, Uthman OA, Vaezghasemi M, Vasankari T, Vlassov VV, Vollset SE, Weiderpass E, Werdecker A, Wesana J, Westerman R, Yano Y, Yonemoto N, Yonga G, Zaidi Z, Zenebe ZM, Zipkin B, Murray CJL. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377(1): 13–27 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical